AJJARAPU SURENDRA K 4

What Happened
Surendra K. Ajjarapu, a director of Wellgistics Health, Inc. (WGRX), received compensation on 2026-03-31 consisting of 5,000,000 shares of common stock (reported at $0.20 each, $1,000,000) and 5,000,000 warrants to purchase common stock (reported at $0.01 each, $50,000). Both grants are reported on a Form 4 filed 2026-04-23 and are coded as award/grant (A). These were issued as compensation for service rather than open‑market purchases or sales.

Key Details

• Transaction date: 2026-03-31; Form 4 filed: 2026-04-23 (appears late — Form 4s are typically due within two business days).
• Awards: 5,000,000 common shares @ $0.20 (value $1,000,000) and 5,000,000 warrants @ $0.01 (value $50,000).
• Total reported value on grant: ~$1,050,000.
• Shares owned after transaction: not disclosed in the filing.
• Footnotes: F1 — shares issued as compensation exempt from registration under Section 4(a)(2); F2 — warrants issued as compensation exempt under Section 4(a)(2).
• Transaction code: A = Award/Grant; the warrant grant is a derivative security (the filing lists it as a derivative acquisition).

Context
These grants are compensation for service and should be read as corporate equity compensation rather than insider buying/selling of existing shares. Warrants are a derivative right to acquire shares under terms set by the issuer (the filing lists the warrant grant but does not detail exercise terms or expiration). The filing date is significantly later than the transaction date, which may be notable for monitoring insider reporting timeliness.